ron disease; the mutation was recently localized to a tubulin chaperone E gene [3, 4].
). Thus, the incidence of synaptic pathology was twice as great in pmn/pmn transport of fluorogold was slower in pmn/pmn mice at P15 and preceded the onset of soma degeneration mutants as in pmn/pmn;Wlds mice; this finding provides a cellular basis for the behavioral improvement docu-( Figures 3A-3C ). The presence of the Wlds allele rescued retrograde transport of fluorogold completely at P15 and mented above.
Together, our data demonstrate the ability of the Wlds P30 and significantly at P40. Thus, Wlds affects not only the integrity of the myelinated axons, but it also protects protein to postpone axon degeneration, preserve neuromuscular structure, delay transport or uptake defects, against impaired axonal transport, diminished axonal uptake, or reduced numbers of axons transporting the attenuate symptoms, and extend life span in mice with a "dying back" motoneuronopathy. In contrast, the antitracer molecule, all of which represent important components of axon metabolism. Percentage of synaptic sites in cross-sections of tibialis muscles at 30 days of age in control (n ϭ 3), pmn/pmn (n ϭ 4), and pmn/pmn;Wlds mice (n ϭ 3). The number of synapses in pmn/pmn;Wlds mice was significantly greater than in pmn/pmn mice.
